Elekta’s new Leksell Vantage Stereotactic System improves

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Sep 28, 2016 at 1:45 AM

Elekta’s new Leksell Vantage Stereotactic System improves imaging and workflow for neurosurgery procedures

Novel head frame designed for greater patient comfort and improved clinical workflow MADRID, September 28, 2016 – Elekta (EKTA-B.ST) introduces Leksell® Vantage™ Stereotactic System, its latest system for very precise neurosurgery, at the European Society for Stereotactic and Functional Neurosurgery (ESSFN) meeting, September 28 – October 1, in Madrid. Based on the Leksell Stereotactic System®, which is considered the gold standard within stereotactic neurosurgery, Leksell Vantage addresses the limitations of using metal components during stereotactic MR and CT imaging. Constructed of a novel epoxy composite, the robust, metal-free head frame design may allow for faster and better stereotactic imaging. This means higher resolution MR imaging of the brain and fewer artifacts introduced in stereotactic CT scanning. Dee Mathieson, Senior Vice President, Treatment Management Portfolio, says: “Building on our heritage and the invention of Lars Leksell, Elekta’s founder, our current Leksell Stereotactic Systems have been employed in more than 1,500 centers worldwide. We expect the benefits of Leksell Vantage to make our system even more competitive as it allows for faster stereotactic neuroimaging without compromise, and with fewer components it results in a smoother workflow.” Also important to clinicians is the new stereotactic arc, a surgical positioning device which enables a faster preparation of the sterile field. Target coordinates are easily set between the left and the right brain hemisphere in deep brain stimulation (DBS) lead placements. Leksell Vantage’s lightweight, open face design is created to improve the patient experience. In addition to making it easier to eat or drink while the frame is on, it has the potential to reduce MR scanning times. It essentially eliminates the risk of device-related skin sensations due to temperature increase during MR scans. Stereotactic neurosurgery is a specialty often used for DBS implantations, brain biopsies, drug deliveries to delicate brain targets, as well as cranial radiosurgery. Leksell Vantage Stereotactic System is expected to be available for clinical use in Europe during 2017. The Leksell Vantage head frame is designed to be compatible with Leksell Gamma Knife® Icon™ in a future release. Leksell® Vantage™ Stereotactic System is not yet CE marked or 510(k) cleared and is not available for sale or distribution. # # # For further information, please contact: Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com Time zone: CET: Central European Time Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com Time zone: CET: Central European Time The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on September 28, 2016. About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,600 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Top 5 Most Recently Viewed Articles

Topicus.com Inc. Reports Impressive Q3 Growth in Earnings

Topicus.com Inc. Achieves Record Financial Results in Q3 2024 Today, Topicus.com Inc. (TSXV: TOI) has shared promising financial data for the third quarter of 2024, indicating a strong upward trajectory in both revenue and profits. This positive news reflects a robust business performance managed under the guidance of Constellation Software Inc. (TSX: CSU). All figures...

Rumble Experiences Significant Stock Surge with Dr Disrespect Deal

Rumble Stock Experiences Notable Increase Rumble has recently witnessed a remarkable surge in its shares, jumping by as much as 17%. This increase represents the most significant intraday rise seen since July, attributed to an exciting partnership with gaming sensation Dr Disrespect. Exclusive Streaming Agreement with Dr Disrespect Under the partnership, Dr Disrespect...

Michelin's Recent Trading Insights and Share Buyback Strategy

Understanding Michelin's Share Buyback Initiative Michelin, well-known for its premium tire products, has been actively engaging in share repurchase activities. This initiative is significant for any investor as it showcases the company's robust financial health and strategic approach to increasing shareholder value. By buying back its shares, Michelin signals confidence...

Treasury Yields Remain Steady as Inflation Data Looms

Treasury Yields Steady Ahead of Key Inflation Data Treasury rates are not changing much while the market waits for important inflation figures. Investor caution is high in the last week of June. They are delaying significant actions until the report on Friday. Slightly higher is the yield on the 10-year Treasury. Similar little gains are seen in the two-year yield. The...

MDPI Set to Transform Peer Review with Innovative Technology

MDPI's Innovations in Peer Review MDPI, a leading open access (OA) publisher, is transforming the peer review process with new technology. This initiative ties in seamlessly with the upcoming Peer Review Week 2024, which focuses on 'Innovation and Technology in Peer Review'. Set to take place at the end of September, this event aims to showcase the evolving world of...